You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clinical Trial, Phase I

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

Not yet recruiting
  • Non-muscular Invasive Bladder Cancer
  • BCG for therapeutic use
  • Changsha, China
    Hunan Cancer Hospital
Oct 20, 2023

Advanced Solid Tumors Trial (SHR-1826)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 16, 2023

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023

Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

Not yet recruiting
  • Liver Cancer
  • Stereotactic Body Radiation Treatment
  • Kansas City, Kansas
    University of Kansas Medical Center
Feb 13, 2023

Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,

Recruiting
  • Hand, Foot and Mouth Disease
  • Herpangina
  • low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
  • +3 more
  • Chuxiong, Yunnan, China
    Dayao County Center for Disease Control and Prevention
Sep 25, 2023

Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)

Not yet recruiting
  • Overweight or Obesity
  • Xenical® vs EMP 22
  • +2 more
  • Uppsala, Sweden
    CTC Clinical Trial Consultanta AB
Aug 25, 2023

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine(Sf9 cell)
  • (no location specified)
Mar 10, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Hypertension, Dyslipidemias Trial (CKD-348(6), CKD-828, D097, D337)

Not yet recruiting
  • Hypertension
  • Dyslipidemias
  • (no location specified)
Oct 29, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Nov 15, 2023

Cancer Trial in L'Hospitalet de Llobregat (MBF-362)

Recruiting
  • Cancer
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Instituto Catalan de Oncología
Jul 7, 2023

Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)

Active, not recruiting
  • Tuberculosis
  • Seattle, Washington
    Fred Hutchinson Cancer Center
Dec 9, 2022

Malaria Trial in Arzo (pyronaridine artesunate)

Completed
Has Results
  • Malaria
  • pyronaridine artesunate clinical trial reference tablets
  • pyronaridine artesunate to-be-marketed tablets
  • Arzo, Switzerland
    Cross Research S.A., Phase I Unit
Feb 1, 2023

Herpes Zoster Trial (Recombinant Zoster Vaccine, Placebo, Zoster Vaccine Recombinant, Adjuvanted)

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine
  • +2 more
  • (no location specified)
Feb 6, 2023

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

NSCLC Trial in France (TG6050)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Bordeaux, France
  • +3 more
Mar 15, 2023

Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

Not yet recruiting
  • Human Papillomavirus Infection
  • Human papillomavirus (HPV) Vaccine
  • Placebo
  • Canberra, Australia
    Paratus Clinical Research Canberra
Jan 4, 2023

Advanced Malignant Tumors Trial in China (LBL-033 for Injection)

Not yet recruiting
  • Advanced Malignant Tumors
  • LBL-033 for Injection
  • Fuzhou, Fujian, China
  • +5 more
Mar 19, 2023

Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )

Recruiting
  • Diabetes Mellitus, Type 2
  • AP026 (TQA2226) for injection
  • AP026 (TQA2226) for injection matching placebo
  • Changchun, Jilin, China
    The first hospital of Jilin University
Nov 16, 2023